Regonix 40mg ( Regorafenib )

Product Name : Regonix ( Regorafenib )
Generic Name : Regorafenib
Formulation : Tablet
Available Pack Size : 28’s
Available Strengths : 40mg
Registrations : Bangladesh
Category:

Product Description

What is Regonix 40mg?

Regorafenib 40mg contains the active ingredient of Regorafenib 40mg, which is an antineoplastic, tyinine kinase inhibitor. Regonix 40mg is a product of Beacon pharmaceutical used for colorectal cancer and liver cancer treatment.

Basic information of the drug Regonix 40mg

  • Active ingredient: Regorafenib
  • Class: Anticancer drug. Tyinine kinase inhibitors.
  • Dosage form: Tablets.
  • Packaging: Box of 28 tablets.
  • Origin: Beacon.

Ingredients

  • Regorafenib 40mg
Pharmacological properties and mechanism of action

Pharmacodynamic:

  • Regorafenib is indicated for treating patients with metastatic colorectal cancer (CRC) who have been previously treated with or are not considered candidates for, a chemotherapy-derived regimen. fluoropyrimidine, anti-VEGF therapy, and an anti-EGFR therapy if the patient has wild-type KRAS.
Similar drugs
  • Stivarga 40mg
  • Erbitux 5mg/ml
  • Oxitan 50mg/25ml
  • Irinotesin 40mg
简体中文繁體中文NederlandsEnglishFrançaisDeutschItalianoLatviešu valodaLietuvių kalbaEspañolTürkçeУкраїнська